These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2767124)

  • 1. Correlation between fall in blood pressure and in vivo amine release after alpha-methylDOPA.
    Kapoor V; Chalmers J
    Eur J Pharmacol; 1989 May; 164(3):531-8. PubMed ID: 2767124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenaline depletion in the hypothalamus of the rat after chronic alpha-methyldopa.
    Beart PM; Prosser D; Louis WJ
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):25-31. PubMed ID: 7471519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute and chronic administration of alpha-methyldopa: regional levels of endogenous and alpha-methylated catecholamines in rat brain.
    Conway EL; Louis WJ; Jarrott B
    Eur J Pharmacol; 1978 Dec; 52(3-4):271-80. PubMed ID: 729639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the role of alpha-methyldopamine in the antihypertensive effect of alpha-methyldopa.
    Waldmeier P; Hedwal PR; Maître L
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 289(3):303-14. PubMed ID: 169487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-methyladrenaline: a possible active metabolite of alpha-methyldopa in the rat brain.
    Himeno A; Kunisada K; Niwa M; Ozaki M
    Jpn J Pharmacol; 1985 Sep; 39(1):91-8. PubMed ID: 4068393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic ethanol administration attenuates imidazoline I1 receptor- or alpha 2-adrenoceptor-mediated reductions in blood pressure and hemodynamic variability in hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    Eur J Pharmacol; 2004 Feb; 485(1-3):251-62. PubMed ID: 14757148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypotension and hypothalamic amine metabolism after long-term alpha-methyldopa infusions.
    Freed CR; Quintero E; Murphy RC
    Life Sci; 1978 Jul; 23(4):313-22. PubMed ID: 357873
    [No Abstract]   [Full Text] [Related]  

  • 9. alpha-Methyldopa, alpha-methyldopamine an alpha-methylnoradrenaline: substrates for the thermolabile form of human platelet phenol sulphotransferase.
    Mwaluko G; Weinshilboum R
    Br J Clin Pharmacol; 1982 Aug; 14(2):231-9. PubMed ID: 7049213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of alpha-methyldopa on dopamine synthesis and release in rat striatum in vitro.
    Uretsky NJ; Chase GJ; Lorenzo AV
    J Pharmacol Exp Ther; 1975 Apr; 193(1):73-87. PubMed ID: 237116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous and alpha-methylated catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain after chronic alpha-methyldopa administration.
    Conway EL; Louis WJ; Jarrott B
    Neuropharmacology; 1979 Mar; 18(3):287-90. PubMed ID: 440536
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):186-93. PubMed ID: 5492891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-Monofluoromethyldopa (MFMD) in combination with L-DOPA Effects on tissue catecholamines and blood pressure in rats.
    Johansson P; Henning M
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):28-31. PubMed ID: 7144925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavodilol: a new antihypertensive agent that preferentially depletes peripheral biogenic amines.
    Blosser JC; McCreedy S; Parker RB; Kinsolving CR; Watkins BE; Wu ES
    J Cardiovasc Pharmacol; 1989 Jul; 14(1):142-56. PubMed ID: 2475706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
    Gulati OD; Parikh HM; Ringe SY; Sherlekar ML
    Br J Pharmacol; 1970 Dec; 40(4):689-701. PubMed ID: 5495174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release.
    Wolf WA; Bobik A
    Eur J Pharmacol; 1989 Apr; 163(1):43-53. PubMed ID: 2472968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood pressure and noradrenaline levels after treatment with alpha-methyldopa, alpha-methyldopamine and alpha-methyl-m-tyrosine.
    Henning M
    J Pharm Pharmacol; 1967 Nov; 19(11):775-9. PubMed ID: 4383705
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential blood pressure responses to intracisternal clonidine, alpha-methyldopa, and 6-hydroxydopamine in conscious normotensive and spontaneously hypertensive rats.
    Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(4):735-42. PubMed ID: 2427812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure and hypothalamic NA-GABA interaction in spontaneously hypertensive rats (SHR): effect of administration DSP-4.
    Goźlińska B; Czyzewska-Szafran H; Płaźnik A
    Acta Pol Pharm; 1999; 56(3):245-8. PubMed ID: 10635362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of acute alpha-methyldopa administration on catecholamine levels in anterior hypothalamic-preoptic and medullary nuclei in rat brain [proceedings].
    Conway EL; Jarrott B; Louis WJ; Beart PM
    Br J Pharmacol; 1978 Mar; 62(3):405P-406P. PubMed ID: 638336
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.